| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |